Several new treatment options for patients with breast cancer have emerged over the last few years, including more oral ...

University of Kentucky Markey Cancer Center researchers have discovered a promising new way to combat therapy-resistant ...

The University of Iowa study is analyzing the period between breast cancer diagnosis and treatment, when many patients feel ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.DN-d7ZPu.js ...

Enhertu is a HER2-directed antibody and topoisomerase inhibitor conjugate. Approval of the new indication was based on data from the phase 3 DESTINY-Breast06 trial (ClinicalTrials.gov Identifier: ...

Dr. Arpita Chowdhury, a medical officer with expertise in breast cancer care, emphasized the importance of awareness like ...

With Hologic, Inc. HOLX gearing up to release its fiscal 2025 first-quarter financial results on Feb. 5 after the market ...

Discover new treatments currently being developed for pancreatic cancer, which has historically been extremely difficult to ...

Dewpoint Therapeutics’ second development candidate, DPTX3496 is an oral, small molecule acting via a novel condensate-modulating mechanism of ...

Triple negative breast cancer wreaks a particularly heavy toll in certain regions and populations, with stark differences in both incidence and survival rates ...

Breast cancer is more common after menopause than many realise, and understanding the risks, treatment options, and ...

A seasoned global health specialist has called for innovative and robust funding streams to escalate the treatment of cancer in Zambia.